STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Mesker, W, Johnstone, E, Van Pelt, G, Midgley, R, Liefers, G, Morreau, J, Kerr, D, Tollenaar, R
Formato:	Conference item
Publicado em:	2010

Registros relacionados

Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients
por: Mesker, W, et al.
Publicado em: (2010)

Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage I-II Colon Cancer Patients
por: Mesker, W, et al.
Publicado em: (2011)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
por: Mesker, W, et al.
Publicado em: (2010)

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
por: Huijbers, A, et al.
Publicado em: (2013)

THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS
por: Mesker, W, et al.
Publicado em: (2012)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Wilma E. Mesker, et al.
Publicado em: (2009-01-01)

Filling the gap between microscopic and automated analysis of the tumor-stroma ratio
por: Gabi Pelt, et al.
Publicado em: (2020-03-01)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
por: Marloes A. Smit, et al.
Publicado em: (2023-01-01)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
por: Wilma E. Mesker, et al.
Publicado em: (2007-01-01)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado em: (2021-03-01)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Marloes A Smit, et al.
Publicado em: (2020-11-01)

Prognosis prediction of stage II colon cancer by gene expression profiling
por: Capella, MG, et al.
Publicado em: (2007)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
por: Midgley, R, et al.
Publicado em: (2013)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Cor J. Ravensbergen, et al.
Publicado em: (2021-10-01)

Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer
por: Takashi Okuyama, et al.
Publicado em: (2020-09-01)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
por: G.W. van Pelt, et al.
Publicado em: (2020-01-01)

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
por: Yong Chen, et al.
Publicado em: (2020-12-01)

DSG2 expression is low in colon cancer and correlates with poor survival
por: Tingting Yang, et al.
Publicado em: (2021-01-01)

Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients
por: Yutong Lou, et al.
Publicado em: (2024-06-01)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
por: Midgley, R, et al.
Publicado em: (2005)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute<it>⊕ </it>Study
por: Pruijt Hans FM, et al.
Publicado em: (2011-05-01)

High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
por: Elizabeth Morrow, et al.
Publicado em: (2023-06-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
por: Midgley, R, et al.
Publicado em: (2005)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
por: Kerr, D, et al.
Publicado em: (2010)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
por: Kerr, D, et al.
Publicado em: (2010)

Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels
por: Arentz Georgia, et al.
Publicado em: (2011-12-01)

Cancer of the Colon and Rectum: Treatment: Chemotherapy
por: Sabharwal, A, et al.
Publicado em: (2009)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Zeyan Xu, et al.
Publicado em: (2021-10-01)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
por: Tanke Hans J, et al.
Publicado em: (2010-04-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado em: (2024)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Hannah Si Hui Lau, et al.
Publicado em: (2023-10-01)

Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer
por: Jianhong Peng, et al.
Publicado em: (2024-06-01)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Hyeon Jeong Oh, et al.
Publicado em: (2017-05-01)

High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer
por: Hongsheng Fang, et al.
Publicado em: (2024-12-01)

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
por: Dan Jiang, et al.
Publicado em: (2021-09-01)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
por: Koukourakis, M, et al.
Publicado em: (2003)

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
por: Shahid Hussain, et al.
Publicado em: (2020-12-01)

The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
por: Yanghong Ni, et al.
Publicado em: (2021-05-01)

Prognostic factors of overall survival for patients with stage II colon cancer
por: Harsha Trivedi, et al.
Publicado em: (2014-11-01)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
por: Karina Vázquez-Arreguín, et al.
Publicado em: (2023-06-01)